Latest Stock Market News

Indian benchmark indices Sensex and Nifty opened lower on Friday due to weak global cues and IT stocks decline. U.S. President Trump s new tariffs have sparked fears of a global recession, leading to significant market losses. Wall Street saw its largest single-day percentage drop since 2020.

Rate this item

(1 Vote)

Rate this item

(1 Vote)

"RSI trending up" means that the Relative Strength Index (RSI) values are increasing, suggesting strengthening momentum in the price of the stock

Investors took profits from precious metals following US President Trump s imposition of reciprocal tariffs. Gold futures fell by 0.65%, and silver saw heavier profit booking, dropping by 1.6%. Market volatility is expected to persist, influenced by the dollar index and global trade tensions.

In a volatile market, bonds are gaining popularity for their predictable returns and capital efficiency over traditional options like fixed deposits. Suresh Darak urges retail investors to allocate a portion of their portfolios to bonds for better income, risk management, and overall portfolio efficiency.

India now faces a 26% tariff, higher than expected but still significantly lower than the 54% levied on China.

We have collated a list of recommendations from top brokerage firms from ETNow and other sources.

Gold prices have surged nearly 20% in 2025 due to global economic uncertainties and the ongoing tariff war. However, the rally faces resistance at Rs 91,000 on MCX and $3,150 per troy ounce on COMEX, signaling a potential short-term pullback amid market volatility.

Add TCS, target price Rs 3,900: Emkay Global

Updated at : 2025-04-04 14:20:02

Rate this item

(1 Vote)

Emkay Global Financial Services recommends adding Tata Consultancy Services (TCS) with a target price of Rs 3,900. Currently, TCS is priced at Rs 3,440. For the quarter ending December 2024, TCS reported a total income of Rs 65,216 crore and a net profit of Rs 12,444 crore. Promoters hold 71.77% stake in the company.

Shares of Indian pharma companies, including Aurobindo Pharma, Laurus Labs, IPCA Labs, and Lupin, fell up to 7% after U.S. President Donald Trump hinted at imminent tariffs on pharmaceutical imports. Speaking aboard Air Force One, Trump said pharma would be treated as a separate tariff category, reversing earlier expectations that the sector would remain exempt from trade restrictions.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.